TABLE 2.
Parameters | Groups | Assessment timeline | 95% CI | p-value** | Effect size (d) a | |
---|---|---|---|---|---|---|
Baseline | 6-week | |||||
Serum cortisol (nmol/L) | AT + DMM | 18.08 ± 3.14 | 12.59 ± 2.17 | 4.45:6.52 | 0.0001 | 2.07 |
AT | 18.00 ± 3.34 | 14.37 ± 2.89 | 2.61:4.67 | 0.0001 | 1.17 | |
95% CI | 0.06:0.1 | 3.12:0.4 | ||||
p-value* | 0.93 | 0.01 | ||||
Effect size (d) a | 0.69 | |||||
Fasting blood glucose (mg/dl) | AT + DMM | 159.86 ± 8.73 | 136.79 ± 5.19 | 20.5:25.62 | 0.0001 | 3.31 |
AT | 158.48 ± 10.54 | 142.68 ± 7.16 | 13.23:18.35 | 0.0001 | 1.78 | |
95% CI | 2.23:0.9 | 9.19:2.6 | ||||
p-value* | 0.59 | 0.001 | ||||
Effect size (d) a | 0.94 |
Data are expressed as mean±standard deviation; CI, confidence interval. Statistically significant values of p-value <0.05 are showed in bold.
Denotes p-value between the group.
Denotes p-value within the group.
Treatment effect size (d): large if d = 0.8, medium if d = 0.5, small if d = 0.2.